12:36:38 EDT Thu 28 Oct 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Sept. 22, 2021

2021-09-22 20:00 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index added 3.54 to 139.84, while the CSE Composite Index added 13.11 to 662.52. South of the border, U.S. lawmakers have succeeded in attaching a cannabis banking bill to a crucial piece of defence legislation. The House Rules Committee voted last night to approve the addition of the Secure and Fair Enforcement (SAFE) Banking Act to the National Defense Authorization Act (NDAA).

The SAFE Act would allow banks and other financial institutions to do business with state-legal cannabis companies without fear of federal repercussions. It would not legalize cannabis, but would still help the industry by lowering the cost of capital. SAFE has cleared the House four times but never the Senate. In tethering it to the NDAA, considered a must-pass in Congress, lawmakers are hoping to force the Senate's hand.

There is still no guarantee that SAFE will survive a journey to the Senate floor. The Senate and the House must negotiate the final version of the NDAA, which could see SAFE stripped out. Much will depend on Senate Majority Leader Chuck Schumer and his willingness to consider SAFE when he is already trying to champion his own, broader reform bill. He will have to make up his mind quickly (by a politician's standards); the last day in session is Dec. 10 and the NDAA will have to be ready in some form by then.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2021 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.